Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss
- PMID: 2642485
- DOI: 10.1210/jcem-68-1-173
Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss
Abstract
We studied a group of obese hyperandrogenic amenorrheic women to determine the effects of weight loss on anthropometry, hormonal status, menstrual cycles, ovulation, and fertility. Fourteen women had polycystic ovaries, two the hyperandrogenism-insulin resistance-acanthosis nigricans syndrome, one hirsutism of adrenal origin, and three idiopathic chronic anovulation. The duration of amenorrhea before the study ranged from 3-17 months [mean, 8.6 +/- 4.5 (+/- SD)]. All women ate a hypocaloric diet for a period of 8.0 +/- 2.4 months. Weight loss ranged from 4.8 to 15.2 kg (mean, 9.7 +/- 3.1 kg; 1.35 +/- 0.56 kg/month) and the waist to hip ratio, which was used as a measurement of body fat distribution, decreased from 0.86 +/- 0.1 to 0.81 +/- 0.06 (P less than 0.0001). The women's mean plasma testosterone and LH concentrations decreased significantly (P less than 0.001 and P less than 0.005, respectively). A significant positive correlation was found between the decreases in plasma testosterone levels and the decreases in glucose-stimulated insulin levels. Moreover, the decreases in the waist to hip ratio correlated positively with the decreases in glucose-stimulated insulin levels and inversely with the decreases in plasma 17 beta-estradiol. No relationships were found between weight loss and the changes in plasma insulin, steroid, and gonadotropin concentrations. The responsiveness to the weight reduction program was evaluated by comparing the number of menstrual cycles during the study period with the number reported before it. Eight women had significantly improved menstrual cyclicity (responders), while 12 did not (nonresponders). The clinical characteristics and hormone values were similar in responder and nonresponder women. In the group as a whole, 33% of the menstrual cycles during the study were ovulatory, and 4 pregnancies occurred. Hirsutism improved significantly in more than half of the women, as did acanthosis nigricans when present. We conclude that weight loss is beneficial in all obese hyperandrogenic women regardless of the presence of polycystic ovaries, the degree of hyperandrogenism, and the degree and distribution of obesity.
Similar articles
-
Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.J Clin Endocrinol Metab. 2000 Aug;85(8):2767-74. doi: 10.1210/jcem.85.8.6738. J Clin Endocrinol Metab. 2000. PMID: 10946879 Clinical Trial.
-
17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss.J Clin Endocrinol Metab. 1997 Feb;82(2):556-60. doi: 10.1210/jcem.82.2.3753. J Clin Endocrinol Metab. 1997. PMID: 9024253
-
Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.J Clin Endocrinol Metab. 1987 Sep;65(3):499-507. doi: 10.1210/jcem-65-3-499. J Clin Endocrinol Metab. 1987. PMID: 3305551
-
Interrelationships between body weight, body fat distribution and insulin in obese women before and after hypocaloric feeding and weight loss.Ann Nutr Metab. 1989;33(2):79-87. doi: 10.1159/000177524. Ann Nutr Metab. 1989. PMID: 2683982 Review.
-
Lipid metabolism and hyperandrogenism.Clin Obstet Gynecol. 1991 Dec;34(4):864-71. doi: 10.1097/00003081-199112000-00024. Clin Obstet Gynecol. 1991. PMID: 1778028 Review.
Cited by
-
Risk Factors for Infertility in Korean Women.J Korean Med Sci. 2024 Mar 18;39(10):e85. doi: 10.3346/jkms.2024.39.e85. J Korean Med Sci. 2024. PMID: 38501182 Free PMC article.
-
Endocrine Disrupting Chemicals in Polycystic Ovary Syndrome: The Relevant Role of the Theca and Granulosa Cells in the Pathogenesis of the Ovarian Dysfunction.Cells. 2022 Dec 31;12(1):174. doi: 10.3390/cells12010174. Cells. 2022. PMID: 36611967 Free PMC article. Review.
-
Ovulation induction techniques in women with polycystic ovary syndrome.Front Med (Lausanne). 2022 Aug 12;9:982230. doi: 10.3389/fmed.2022.982230. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36035398 Free PMC article. Review.
-
Efficacy of Spironolactone in Adult Acne in Polycystic Ovary Syndrome Patients an Original Research.J Pharm Bioallied Sci. 2021 Nov;13(Suppl 2):S1659-S1663. doi: 10.4103/jpbs.jpbs_391_21. Epub 2021 Nov 10. J Pharm Bioallied Sci. 2021. PMID: 35018050 Free PMC article.
-
Cutaneous manifestation of polycystic ovary syndrome.Dermatol Reports. 2021 Sep 15;13(2):8799. doi: 10.4081/dr.2021.8799. eCollection 2021 Aug 1. Dermatol Reports. 2021. PMID: 34659671 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials